| Genename | Variants |
|---|---|
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125864927C>T,c.2383G>A,p.V795I |
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125864878C>T,c.2432G>A,p.R811H |
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125864848C>T,c.2462G>A,p.R821H |
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125864206T>C,c.2623A>G,p.S875G |
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125851029C>T,c.3191G>A,p.S1064N |
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125831735G>A,c.3515C>T,p.P1172L |
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125831724C>T,c.3526G>A,p.V1176I |
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125831699G>A,c.3551C>T,p.P1184L |
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125831676C>T,c.3574G>A,p.D1192N |
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125830970A>T,c.3731T>A,p.I1244N |
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125830926C>T,c.3775G>A,p.E1259K |
| CDON(NM_001243597,cell adhesion associated, oncogene regulated,1287aa) | g.11:125830871G>A,c.3830C>T,p.P1277L |
| CDO1(NM_001801,cysteine dioxygenase type 1,200aa) | g.5:115152049T>C,c.46A>G,p.I16V |
| CDO1(NM_001801,cysteine dioxygenase type 1,200aa) | g.5:115148936C>A,c.190G>T,p.D64Y |
| CDO1(NM_001801,cysteine dioxygenase type 1,200aa) | g.5:115142209A>G,c.410T>C,p.I137T |
| CDO1(NM_001801,cysteine dioxygenase type 1,200aa) | g.5:115142153A>T,c.466T>A,p.L156M |
| CDO1(NM_001801,cysteine dioxygenase type 1,200aa) | g.5:115142095T>C,c.524A>G,p.N175S |
| CDNF(NM_001029954,cerebral dopamine neurotrophic factor,187aa) | g.10:14867562G>A,c.301C>T,p.R101C |
| CDNF(NM_001029954,cerebral dopamine neurotrophic factor,187aa) | g.10:14862082C>G,c.461G>C,p.W154S |
| CDKN3(NM_005192,cyclin-dependent kinase inhibitor 3,212aa) | g.14:54884623A>T,c.506A>T,p.D169V |
| CDKN2D(NM_001800,cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4),166aa) | g.19:10677826C>T,c.409G>A,p.A137T |
| CDKN2B(NM_078487,cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4),78aa) | g.9:22008736G>C,c.217C>G,p.R73G |
| CDKN2A(NM_001195132,cyclin-dependent kinase inhibitor 2A,167aa) | g.9:21974705G>T,c.122C>A,p.P41Q |
| CDKN2A(NM_001195132,cyclin-dependent kinase inhibitor 2A,167aa) | g.9:21970988G>A,c.370C>T,p.R124C |
| CDKN2A(NM_001195132,cyclin-dependent kinase inhibitor 2A,167aa) | g.9:21970916C>T,c.442G>A,p.A148T |
| CDKN2A(NM_001195132,cyclin-dependent kinase inhibitor 2A,167aa) | g.9:21968732G>A,c.496C>T,p.H166Y |
| CDKN2AIP(NM_017632,CDKN2A interacting protein,580aa) | g.4:184367561G>T,c.724G>T,p.A242S |
| CDKN2AIP(NM_017632,CDKN2A interacting protein,580aa) | g.4:184367560_184367562del,c.723_725del,p.241_242del |